BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2024-05

212 industry Phase 2/3 trial readout(s) and 22 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2024-04 | 2024-06 →

FDA decision events

DateEventStatusCompanyDrugSource
2024-05-01FDA approvalapprovedAZURITYMYHIBBINApproved 2024-05-01: MYHIBBIN (NDA216482 ORIG1)
2024-05-03FDA approvalapprovedSAMSUNG BIOEPIS CO LTDETICOVOApproved 2024-05-03: ETICOVO (BLA761066 SUPPL3)
2024-05-03FDA approvalapprovedSAMSUNG BIOEPIS CO LTDETICOVOApproved 2024-05-03: ETICOVO (BLA761066 SUPPL1)
2024-05-07FDA approvalapprovedOTSUKAREXULTIApproved 2024-05-07: REXULTI (NDA205422 SUPPL11)
2024-05-09FDA AdComheldAdCom 2024-05-09: Blood Products Advisory Committee
2024-05-10Complete response lettercomplete responseAccord Healthcare Inc.bendamustine hydrochloride injectionCRL 2024-05-10: Accord Healthcare Inc. NDA 216987 (bendamustine hydrochloride injection)
2024-05-16FDA AdComheldAdCom 2024-05-16: Vaccines and Related Biological Products Advisory Committee
2024-05-16Complete response lettercomplete responseElevar Therapeutics, Inc.CRL 2024-05-16: Elevar Therapeutics, Inc. NDA 216586
2024-05-16Complete response lettercomplete responseJiangsu Hengrui Pharmaceuticals Co., Ltd. JHPCYSHR-1210CRL 2024-05-16: Jiangsu Hengrui Pharmaceuticals Co., Ltd. BLA 761308 (SHR-1210)
2024-05-16FDA approvalapprovedAMGEN INC AMGNIMDELLTRAApproved 2024-05-16: IMDELLTRA (BLA761344 ORIG1)
2024-05-16FDA approvalapprovedGLAXOSMITHKLINE LLCBENLYSTAApproved 2024-05-16: BENLYSTA (BLA761043 SUPPL27)
2024-05-20FDA approvalapprovedBIOCON BIOLOGICS INCYESAFILIApproved 2024-05-20: YESAFILI (BLA761274 ORIG1)
2024-05-20FDA approvalapprovedSAMSUNG BIOEPIS CO LTDOPUVIZApproved 2024-05-20: OPUVIZ (BLA761350 ORIG1)
2024-05-22FDA AdComheldAdCom 2024-05-22: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
2024-05-23FDA AdComheldAdCom 2024-05-23: Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee
2024-05-24FDA AdComheldNovo Nordisk NVOAdCom 2024-05-24: Endocrinologic and Metabolic Drugs Advisory Committee
2024-05-24Complete response lettercomplete responseNeuroDerm, Ltd.CRL 2024-05-24: NeuroDerm, Ltd. NDA 218317
2024-05-24FDA approvalapprovedTRIS PHARMA INCONYDA XRApproved 2024-05-24: ONYDA XR (NDA217645 ORIG1)
2024-05-28FDA approvalapprovedAMGEN INC AMGNBKEMVApproved 2024-05-28: BKEMV (BLA761333 ORIG1)
2024-05-29FDA approvalapprovedELI LILLY AND CO LLYRETEVMOApproved 2024-05-29: RETEVMO (NDA213246 SUPPL12)
2024-05-30FDA approvalapprovedCATALYST PHARMSFIRDAPSEApproved 2024-05-30: FIRDAPSE (NDA208078 SUPPL12)
2024-05-31FDA approvalapprovedBAXTER HLTHCARE CORP BAXCEFAZOLIN IN DEXTROSEApproved 2024-05-31: CEFAZOLIN IN DEXTROSE (NDA207131 SUPPL10)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2024-05 est.P2Ascentage Pharma Group Inc. AAPGNCT03883087 A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I MutationChronic Myeloid Leukemia, Chronic Phaseunknown41
2024-05 est.P2RemeGen Co., Ltd.NCT04782128 Evaluation of RC28-E Injection in Diabetic RetinopathyDiabetic Retinopathyunknown120
2024-05 est.P2Impact Therapeutics, Inc. IBONCT04822961 Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel TreatmentmCRPCunknown285
2024-05 est.P2Kartos Therapeutics, Inc.NCT04878003 Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisPrimary Myelofibrosis (PMF); Post-Polycythemia Vera Myelofibrosis (Post-PV-MF); Post-Essential Thromunknown52
2024-05 est.P2eXIthera PharmaceuticalsNCT05040776 COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU PatientsThrombopenia; Covid19withdrawn
2024-05 est.P3Bio Genuine (Shanghai) Biotech Co., Ltd.NCT05620355 Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.Uterine Fibroids; Heavy Menstrual Bleedingunknown312
2024-05 est.P2Nova Mentis Life Science Corp NVMINCT05832255 An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X SyndromeFragile X Syndrome; Behavior; Cognitive Dysfunctionsuspended10
2024-05 est.P3Pharmbio Korea Co., Ltd.NCT05923918 A Study to Evaluate Safety and Efficacy of PBK_M2101Intestinal Disease; Colonic Diseases; Gastrointestinal Disease; Digestive System Diseaseunknown246
2024-05 est.P3AJU Pharm Co., Ltd.NCT06291194 Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome PatientsDry Eye Syndromesunknown396
2024-05-01P3Janssen Research & Development, LLCNCT03301220 A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple MyelomaSmoldering Multiple Myelomacompleted390
2024-05-01P3Janssen Research & Development, LLCNCT04181827 A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or DaMultiple Myelomaactive not recruiting419
2024-05-01P2Boehringer IngelheimNCT05238675 A Study to Test Whether Different Doses of BI 1291583 Help People With BronchiectasisBronchiectasiscompleted322
2024-05-01P2Hoffmann-La RocheNCT05419388 A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic MelanomaMelanomacompleted93
2024-05-01P2/P3Lavior Pharma Inc.NCT05607979 Restoring Tissue and Evaluating Novel Treatments for Efficacy in WoundsDiabetic Foot Ulcercompleted75
2024-05-01P2Vogenx, Inc. VOGXNCT05721729 Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose ExcursionsPostbariatric Hypoglycemiacompleted15
2024-05-01 est.P2Kunming Pharmaceuticals, Inc.NCT05745311 Study of the KPCXM18 Injection for Treatment of Acute Ischemic StrokeAcute Ischemic Strokeunknown240
2024-05-01 est.P1/P2Shanghai Huaota Biopharmaceutical Co., Ltd.NCT06223308 A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid TumorsAdvanced Solid Tumor; Cervical Cancerunknown54
2024-05-02P2GlaxoSmithKlineNCT03739710 Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)Neoplasmscompleted175
2024-05-02P3Sydnexis, Inc.NCT03918915 The Safety and Efficacy of SYD-101 in Children With MyopiaNearsightedness; Near Sightedness; Near-sightednesscompleted852
2024-05-02P2Akero Therapeutics, IncNCT04767529 A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)NASH - Nonalcoholic Steatohepatitiscompleted128
2024-05-02P2Boehringer IngelheimNCT05161481 A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Hypertension, Portalterminated80
2024-05-02P2Sage TherapeuticsNCT05173012 Study to Evaluate SAGE-324 in Participants With Essential TremorEssential Tremorcompleted146
2024-05-02P2AstraZeneca AZNNCT05432167 A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney DiseaseUncontrolled Hypertension; Chronic Kidney Diseasescompleted195
2024-05-02P3Oculis OCSNCT06128369 A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain FollowinInflammation Eye Pain; Postoperative Cataractterminated117
2024-05-02P2GlaxoSmithKlineNCT06926673 Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3Neoplasmscompleted62
2024-05-03P3Agios Pharmaceuticals, Inc. AGIONCT05144256 A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed Pediatric Pyruvate Kinase Deficiency; Pediatric Hemolytic Anemiaactive not recruiting49
2024-05-03P3Eli Lilly and Company LLYNCT05372419 A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin ofAtopic Dermatitiscompleted90
2024-05-03P2Cocrystal Pharma, Inc. COCPNCT06160531 Influenza Viral Challenge Study of CC-42344 in Healthy ParticipantsInfluenza Acompleted78
2024-05-05P3Shanghai Bao Pharmaceuticals Co., Ltd.NCT06604546 Hyaluronidase Assisted Subcutaneous InfusionHealthycompleted45
2024-05-06P1/P2Hoffmann-La RocheNCT04029688 A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in TAcute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumorsterminated38
2024-05-06P3AO GENERIUMNCT05601999 Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial InfarctionST Elevation Myocardial Infarctioncompleted244
2024-05-07P3Janssen Research & Development, LLCNCT03652064 A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in ParticipantsMultiple Myelomacompleted395
2024-05-07P1/P2MedPacto, Inc.NCT03724851 Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric CancerMetastatic Colorectal Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinomacompleted120
2024-05-07P2/P3Merck Sharp & Dohme LLC MRKNCT03969901 Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial InfectioSuspected or Documented Gram-negative Bacterial Infectioncompleted115
2024-05-07P3Shanghai Henlius BiotechNCT04063163 A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLCExtensive Stage Small Cell Lung Cancercompleted585
2024-05-07P3POLYSAN Scientific & Technological Pharmaceutical CompanyNCT04631484 International Trial of Efficacy of Cytoflavin in Head TraumaHead Trauma,Closedcompleted166
2024-05-07P1/P2Claris Biotherapeutics, Inc.NCT04909450 Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis SubjectsNeurotrophic Keratitiscompleted131
2024-05-07P3Shanghai Henlius BiotechNCT05003245 Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMDAge Related Macular Degenerationcompleted407
2024-05-07P3Alvotech Swiss AG ALVONCT05395091 Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBONDOsteoporosis, Postmenopausalcompleted532
2024-05-07P3Eli Lilly and Company LLYNCT05463744 A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyType 1 Diabetes; Diabetescompleted692
2024-05-07P2SK Plasma Co., Ltd.NCT05666453 A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver TransplantationLiver Transplantationterminated59
2024-05-07 est.P3Qilu Pharmaceutical Co., Ltd.NCT05803642 A Study of Olanzapine in Patients With Acute AgitationAcute Agitationunknown318
2024-05-07P1/P2Hangzhou Gensciences Biopharmaceutical Co., Ltd.NCT06010953 SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand TreatmentMale; Hemophilia A With Inhibitor; Hemophilia B With Inhibitor; Hemophiliacompleted24
2024-05-08P3Alnylam Pharmaceuticals ALNYNCT04153149 HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With CardiomyopathyTransthyretin Amyloidosis (ATTR) With Cardiomyopathyactive not recruiting655
2024-05-08P2Oblato, Inc.NCT04388475 Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaRecurrent Malignant Glioma; Brain Glioblastomacompleted57
2024-05-08P1/P2TyrNovo Ltd.NCT04474470 A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck CancerSolid Tumor, Adult; Squamous Cell Carcinoma of Head and Neck; Colorectal Adenocarcinoma; Metastatic completed52
2024-05-08P2Astellas Pharma IncNCT04641962 A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial MyopathyPrimary Mitochondrial Myopathyterminated34
2024-05-08P2BioMed Valley Discoveries, IncNCT05221320 Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) MalignanciesTumor, Solid; Gastrointestinal Cancerterminated47
2024-05-08P2Inventiva Pharma IVANCT05232071 Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in paNASH - Nonalcoholic Steatohepatitis; Diabetes Mellitus, Type 2completed39
2024-05-09P1/P2CelgeneNCT02773030 A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple MyelomaMultiple Myelomaactive not recruiting466
2024-05-09P2Seagen, a wholly owned subsidiary of PfizerNCT04569032 A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 ExpressionPeripheral T-cell Lymphomacompleted82
2024-05-09P3Stratatech, a Mallinckrodt CompanyNCT05517902 StrataGraft Safety, Tolerability and Efficacy in Pediatric SubjectsSkin Wound; Burns; Trauma-related Woundcompleted1
2024-05-10P3Hoffmann-La RocheNCT03969212 Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsInfluenzacompleted4138
2024-05-10P2Cellaion SANCT04229901 Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failureterminated133
2024-05-10P3Daiichi SankyoNCT04656652 Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPINon-small Cell Lung Canceractive not recruiting605
2024-05-10P2AkesoNCT04870177 Study of AK112 in the Treatment of Advanced Gynecological TumorsGynecologic Cancer; Cancer Metastatic; Ovarian Neoplasms; Cervical Neoplasm; Endometrial Neoplasmscompleted53
2024-05-10P3Asklepion Pharmaceuticals, LLCNCT05253209 A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Ventricular Septal Defect; Atrioventricular Septal Defect; Primum Atrial Septal Defectterminated64
2024-05-10P3Serum Institute of India Pvt. Ltd.NCT05421611 A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARILYellow Fevercompleted1824
2024-05-10P2GeNeuro SANCT05497089 Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC SyndromePost-COVID-19 Syndromecompleted203
2024-05-10P2Biotheus Inc.NCT05844150 A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCSCLCactive not recruiting50
2024-05-10P3ModernaTX, Inc.NCT06354998 A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated AdultsSARS-CoV-2completed217
2024-05-11P3CelgeneNCT01996865 Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.Lymphoma, Non-Hodgkincompleted503
2024-05-11P2Jiangsu vcare pharmaceutical technology co., LTDNCT05814939 Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.Active Ankylosing Spondylitiscompleted180
2024-05-11P3Mimetogen Pharmaceuticals USA, Inc.NCT05848128 Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry EyeDry Eye Syndromes; Dry Eye Disease; Kerato Conjunctivitis Siccacompleted642
2024-05-13P2TikoMed ABNCT03867851 Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet TransplantationDiabetes Mellitus, Type 1terminated7
2024-05-13P2Neuren Pharmaceuticals LimitedNCT05011851 An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman SyndromeAngelman Syndromecompleted17
2024-05-13P2Innovent Biologics (Suzhou) Co. Ltd.NCT05403749 A Study of Longer Interval of IVT IBI302 in Subjects With nAMDNeovascular Age-related Macular Degenerationcompleted132
2024-05-13P2Clarity Pharmaceuticals LtdNCT05407311 64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)Biochemical Recurrence of Malignant Neoplasm of Prostatecompleted53
2024-05-13P3Chong Kun Dang PharmaceuticalNCT05931224 Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination TherapyEssential Hypertensioncompleted346
2024-05-13P1/P2Bristol-Myers Squibb BMYNCT06024174 A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid TuAdvanced Solid Tumorsterminated5
2024-05-14P2Beijing Pearl Biotechnology Limited Liability CompanyNCT04258033 A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)Non-small Cell Lung Cancercompleted145
2024-05-14P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT04417972 The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.Endometriosiscompleted179
2024-05-14P2Janssen Research & Development, LLCNCT05071664 A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisArthritis, Psoriaticcompleted91
2024-05-14P2Provention Bio, a Sanofi CompanyNCT05087628 PRV-3279-2a Trial in Systemic LupusSystemic Lupus Erythematosusterminated28
2024-05-14P3JW PharmaceuticalNCT05814393 To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes MellitusType 2 Diabetes Mellituscompleted200
2024-05-15P3Pfizer PFENCT04281485 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyDuchenne Muscular Dystrophyactive not recruiting114
2024-05-15P2Hoffmann-La RocheNCT04299464 A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum DisoAutism Spectrum Disorder (ASD)completed104
2024-05-15P3BayerNCT04435626 Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (ProportioHeart Failurecompleted6016
2024-05-15P1/P2Compugen Ltd CGENNCT04570839 COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.Endometrial Neoplasms; Ovarian Cancer; Solid Tumor; Head and Neck Cancercompleted48
2024-05-15P2CalciMedica, Inc. CALCNCT04681066 A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRSAcute Pancreatitis; Systemic Inflammatory Response Syndromecompleted216
2024-05-15P3AKARI Therapeutics AKTXNCT04784455 Nomacopan (rVA576) in Transplant Associated Thrombotic MicroangiopathyThrombotic Microangiopathiesterminated10
2024-05-15P2ILiAD BiotechnologiesNCT05116241 Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age ChildrenBordetella Pertussis, Whooping Coughcompleted368
2024-05-15P3Eli Lilly and Company LLYNCT05275400 A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinType 2 Diabetescompleted986
2024-05-15P2Ascletis Pharmaceuticals Co., Ltd.NCT05330143 Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIVHIV-1-infection; HIV Infections; PD-L1 Gene Mutationcompleted19
2024-05-15P3Shanghai Henlius BiotechNCT05346224 A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally AdvancedBreast Cancer; Breast Neoplasms; HER2-positive Breast Canceractive not recruiting900
2024-05-15 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05762458 The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionMajor Depressive Disorder (MDD)unknown240
2024-05-15P2VivaVision Biotech, IncNCT06164743 Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract SurgeryInflammationcompleted91
2024-05-16P3SetPoint Medical CorporationNCT04539964 Vagus Nerve Stimulation for Moderate to Severe Rheumatoid ArthritisRheumatoid Arthritisactive not recruiting243
2024-05-16P2NS Pharma, Inc.NCT04854096 Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With MyelofibrosisPrimary Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis; Post-polycythemia Vera Myelofibterminated7
2024-05-16P2Eli Lilly and Company LLYNCT05616013 Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseObesity; Obese; Overweight or Obesitycompleted507
2024-05-16P3Eli Lilly and Company LLYNCT05738486 A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)Alzheimer's Disease; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseaactive not recruiting1175
2024-05-16P3Cellular Sciences, inc.NCT06037408 The Effect of N115 on Coughing in IPF PatientsIdiopathic Pulmonary Fibrosiscompleted50
2024-05-16P3BiocadNCT06987851 An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSCMultiple Sclerosiscompleted44
2024-05-17P1/P2MedPacto, Inc.NCT03732274 Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLCNon-Small Cell Lung Cancer Metastaticcompleted60
2024-05-17P2Janssen Pharmaceutica N.V., BelgiumNCT05328297 A Study of JNJ-55308942 in the Treatment of Bipolar DepressionBipolar Disordercompleted116
2024-05-17P3Incyte Corporation INCYNCT05456529 Study of Ruxolitinib Cream in Adolescents With Atopic DermatitisAtopic Dermatitis (AD)completed103
2024-05-17P2Novartis Pharmaceuticals NVSNCT05670106 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRMetastatic Castration-Resistant Prostate Cancer (mCRPC)completed62
2024-05-17P3Johnson & Johnson Consumer Inc. (J&JCI) JNJNCT05761574 A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental PainPaincompleted447
2024-05-17P2AstraZeneca AZNNCT06057064 Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response ACOVID-19, SARS-CoV-2completed116
2024-05-18P2InventisBio Co., LtdNCT05504083 Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia PatientsHyperuricemiacompleted121
2024-05-20P3pharmaand GmbHNCT03522246 A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyEpithelial Ovarian Cancer; Primary Peritoneal; Fallopian Tube Cancer; Newly Diagnosed; FIGO Stage IIactive not recruiting1097
2024-05-20P3AbbVie ABBVNCT04026113 Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional ConstipatFunctional Constipation; Irritable Bowel Syndrome With Constipationcompleted438
2024-05-20P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT04950322 A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal CancerGastric or Gastroesophageal Junction Canceractive not recruiting737
2024-05-20P2Osteal Therapeutics, Inc.NCT05607030 A Second Trial of the Abbreviated Protocol Two-Stage ExchangeProsthetic-joint Infectioncompleted76
2024-05-20P2LeviceptNCT05618782 Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the KneePain; Osteo Arthritis Knee; Knee Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseasescompleted518
2024-05-20P2Caliway Biopharmaceuticals Co., Ltd.NCT05736107 A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous FatSubcutaneous Fatcompleted107
2024-05-21P1/P2Genentech, Inc.NCT02500407 A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and CLymphocytic Leukemia, Chronic; Lymphoma, Non Hodgkincompleted713
2024-05-21P3Grifols Therapeutics LLC GRFSNCT03451292 Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and AscitesDecompensated Cirrhosis and Ascitescompleted410
2024-05-21P2AbbVie ABBVNCT04244175 A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresSeizurescompleted154
2024-05-21P2/P3Novavax NVAXNCT05925127 Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesCOVID-19completed994
2024-05-21P2Intuitive Surgical ISRGNCT05946603 IS-002 Phase 2 Prostate Cancer StudyProstate Cancercompleted59
2024-05-21P1/P2GlaxoSmithKlineNCT05975840 Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in MedicalInfluenza, Humancompleted518
2024-05-21P3Click Therapeutics, Inc. CLIKNCT06004388 Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)Migraine; Episodic Migraine; Headache; Headache, Migrainecompleted110
2024-05-21P2Telios Pharma, Inc.NCT06293820 A Study Of TL-925 For The Treatment of ACAllergic Conjunctivitiscompleted80
2024-05-21P3Jiangxi Qingfeng Pharmaceutical Co. Ltd.NCT07563634 Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal EpilepsyEpilepsy, Focalcompleted141
2024-05-22P1/P2Bristol-Myers Squibb BMYNCT01968109 An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Neoplasms by Sitecompleted1482
2024-05-22 est.P2/P3EmeraMedNCT04183595 NBMI Treatment in Patients With Mercury ToxicityMercury Poisoningunknown116
2024-05-22P3UCB Biopharma SRLNCT04294667 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusSystemic Lupus Erythematosuscompleted321
2024-05-22P2Janssen Research & Development, LLCNCT04633447 A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell ArteritisGiant Cell Arteritisterminated53
2024-05-22P1/P2Nanjing Leads Biolabs Co.,LtdNCT05102006 A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant TumorsAdvanced Malignant Tumorscompleted80
2024-05-22P2Contera Pharma A/SNCT05516875 Open-Label Extension Study of ASTORIADyskinesiasterminated6
2024-05-22P1/P2Teva Branded Pharmaceutical Products R&D LLCNCT05590377 A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaMultiple Myelomaterminated15
2024-05-22P2/P3Nektar Therapeutics NKTRNCT05664217 NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell LymphomaNon-Hodgkin Lymphoma; Relapsed/Refractory Diffuse Large B-cell Lymphomaterminated15
2024-05-22 est.P1/P2Shandong New Time Pharmaceutical Co., LTDNCT05740215 Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid TumorsSolid Tumorsunknown158
2024-05-22P2Ocular Therapeutix, Inc. OCULNCT05814757 OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)Dry Eye Syndromes; Eye Diseasescompleted100
2024-05-22P1/P2Tango Therapeutics, Inc. TNGXNCT06065059 Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsBreast Cancer; Ovarian Cancer; Pancreas Cancer; Prostate Cancer; BRCA1 Mutation; BRCA-Mutated Ovariaterminated7
2024-05-22P3Taejoon Pharmaceutical Co., Ltd.NCT06427031 Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases PatientsDry Eye; Dry Eye Syndromescompleted271
2024-05-23P1/P2Translational Biosciences TDACNCT02192736 Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of AsthmaAsthmaterminated20
2024-05-23P3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT03355209 A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromLennox Gastaut Syndromecompleted296
2024-05-23P2Sanofi SNYNCT05002777 Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)Warm Autoimmune Hemolytic Anemia (wAIHA)active not recruiting22
2024-05-23P2Albimmune SLNCT05645887 Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.Septic Shockwithdrawn
2024-05-23P3Sinovac Biotech Co., Ltd SVANCT06049927 A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 MonthsSeasonal Influenzacompleted3300
2024-05-24P3AstraZeneca AZNNCT03927157 Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled AsthmaAsthmacompleted405
2024-05-24P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04796623 A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast CancerHR-positive, HER2-negative Advanced Breast Cancercompleted122
2024-05-24P3G1 Therapeutics, Inc.NCT04799249 Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)TNBC - Triple-Negative Breast Cancer; Breast Cancercompleted194
2024-05-24P3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT04820309 An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)Schizophreniacompleted566
2024-05-24P2UCB Biopharma SRLNCT04867616 A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)Alzheimer's Diseasecompleted466
2024-05-24P1/P2Eisai Inc.NCT04971733 A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's DiseaAlzheimer Diseasecompleted8
2024-05-24P2/P3ALX Oncology Inc. ALXONCT05002127 A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Gastric Adenocarcinomacompleted127
2024-05-24P1/P2Wave Life Sciences USA, Inc. WVENCT05032196 Study of WVE-003 in Patients With Huntington's DiseaseHuntington Diseasecompleted47
2024-05-24P2Rivus Pharmaceuticals, Inc.NCT05284617 Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEFHeart Failure With Preserved Ejection Fractioncompleted67
2024-05-24P3Bio-Thera SolutionsNCT05377944 Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis PatientsPlaque Psoriasiscompleted502
2024-05-24P2RAPT Therapeutics, Inc., a member of the GSK plc group of companiesNCT05399368 An Efficacy and Safety Study of RPT193 in Adults With Atopic DermatitisAtopic Dermatitisterminated229
2024-05-24P1/P2Genmab GMABNCT05435339 A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as MonotherapySolid Tumor, Adultterminated31
2024-05-24 est.P3Qilu Pharmaceutical (Hainan) Co., Ltd.NCT05922436 a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergencyHypertensive Emergencyunknown378
2024-05-24P2Inventprise Inc.NCT06077656 Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate VaccinePneumococcal Vaccinescompleted220
2024-05-24P2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07278830 A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed DyslipidemiaHypercholesterolemia and Mixed Dyslipidemiacompleted214
2024-05-25P3Takeda TAKNCT03999996 Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster DoseDengue Fevercompleted365
2024-05-25 est.P2/P3Jiangsu Healthy Life Innovation Medical Technology Co., LtdNCT05661240 Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields (EFE-P100)Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With DiseasNon-small Cell Lung Cancer (NSCLC)unknown348
2024-05-25P3Johnson & Johnson Consumer Inc. (J&JCI) JNJNCT05868122 A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following BunionectomyPaincompleted143
2024-05-26P2Shanghai Longwood Biopharmaceuticals Co., Ltd.NCT06800157 Study of LW402 Tablets in Moderate to Severe Rheumatoid ArthritisArthritis, Rheumatoidcompleted72
2024-05-27P3Gilead Sciences GILDNCT04994509 Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV InfectionPre-Exposure Prophylaxis of HIV Infectionactive not recruiting5368
2024-05-27P3Swedish Orphan BiovitrumNCT05096403 A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)Cold Agglutinin Diseasecompleted24
2024-05-27P2Pierre Fabre MedicamentNCT05195632 Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung CancerNon-Small Cell Lung Canceractive not recruiting63
2024-05-27P2Celon Pharma SANCT05374785 Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid ArthritisRheumatoid Arthritiscompleted106
2024-05-27P2Regeneron Pharmaceuticals REGNNCT05618808 A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult ParticipantsVenous Thromboembolismcompleted373
2024-05-27 est.P1/P2Guangdong Ruishun Biotech Co., LtdNCT05858814 RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCTAcute Myeloid Leukemiaunknown72
2024-05-27P2Pfizer PFENCT06116591 A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy ToddlersHealthy Participantscompleted105
2024-05-27P3GlaxoSmithKlineNCT06956170 All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple MyelomaMultiple Myelomaactive not recruiting21
2024-05-28P2Bristol-Myers Squibb BMYNCT02927769 A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line TreaHodgkin Diseasecompleted72
2024-05-28P1/P2BioNTech SE BNTXNCT04455620 BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid TumorsSolid Tumorterminated49
2024-05-28P3Amgen AMGNNCT04524273 Myasthenia Gravis Inebilizumab TrialMyasthenia Gravisactive not recruiting238
2024-05-28P3Hoffmann-La RocheNCT04660539 A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)Neuromyelitis Optica Spectrum Disordercompleted119
2024-05-28P3Arcutis Biotherapeutics, Inc. ARQTNCT04804605 Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisAtopic Dermatitis Eczemacompleted1220
2024-05-28P3Eurofarma Laboratorios S.A.NCT04972292 Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar ExtractionPaincompleted288
2024-05-28P3Eurofarma Laboratorios S.A.NCT05081102 Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar ExtractionPaincompleted288
2024-05-28P3Sedana MedicalNCT05327296 Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive CSedationcompleted282
2024-05-28P3NewAmsterdam Pharma NAMSNCT05425745 Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.Dyslipidemias; High Cholesterol; Hypercholesterolemia; Familial Hypercholesterolemia; Lipid Metabolicompleted354
2024-05-28P2UCB Biopharma SRLNCT05643794 A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia SyndromeFibromyalgiacompleted63
2024-05-28P2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05689047 Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)Acute Malariacompleted38
2024-05-28 est.P1/P21Globe Biomedical Co., Ltd.NCT05784779 Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLDNASH; NAFLDunknown180
2024-05-28P3GlaxoSmithKlineNCT06025695 Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given inGastroenteritiscompleted2000
2024-05-28P3ModernaTX, Inc.NCT06097273 A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of AgeSARS-CoV-2; Influenzacompleted8061
2024-05-28P3Qilu Pharmaceutical (Hainan) Co., Ltd.NCT06932107 Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingPostoperative Nausea and Vomitingcompleted518
2024-05-29P2Cognition Therapeutics CGTXNCT03507790 A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.Mild to Moderate Alzheimer's Diseasecompleted153
2024-05-29P3Alzheon Inc.NCT04770220 An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsEarly Alzheimer's Diseasecompleted325
2024-05-29P2Unicycive Therapeutics, Inc UNCYNCT06218290 A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on DialysisChronic Kidney Disease Requiring Chronic Dialysiscompleted106
2024-05-30P2TheraviaNCT03806452 SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)Sickle Cell Diseasecompleted86
2024-05-30 est.P2Shanghai Henlius BiotechNCT03941574 A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard TherapyMSI-H Solid Malignant Tumorunknown108
2024-05-30 est.P2Shanghai Henlius BiotechNCT04297995 Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck TumorsHead and Neck Squamous Cell Carcinomaunknown131
2024-05-30P2MGC Pharmaceuticals d.o.oNCT04406948 Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant EpilepsiesResistant Epilepsy, Drug; Adolescent Epilepsy; Children Epilepsy; Children and Adolescents With Resiwithdrawn
2024-05-30 est.P2Nature Cell Co. Ltd.NCT04482413 Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's DiseaseAlzheimer Diseaseunknown100
2024-05-30 est.P2Tianjin Chasesun Pharmaceutical Co., LTDNCT04803955 Efficacy and Safety of Kukoamine B Mesilate in Sepsis PatientsSepsisunknown424
2024-05-30P3LIB Therapeutics LLCNCT05004675 Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD PatientsHypercholesterolemia; Atherosclerotic Ischemic Diseasecompleted166
2024-05-30P2Jazz Pharmaceuticals JAZZNCT05122650 A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)Essential Tremorcompleted420
2024-05-30 est.P1/P2Galecto Biotech ABNCT05240131 A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (Non-Small Cell Lung Cancerunknown88
2024-05-30 est.P3Glenmark Pharmaceuticals Ltd. IndiaNCT05363202 To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial AsthmaBronchial Asthmaunknown790
2024-05-30 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT05396339 A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.Advanced Malignant Solid Tumorunknown120
2024-05-30 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT05396391 A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsAdvanced Malignant Tumorsunknown140
2024-05-30 est.P1/P2ZEO ScientifiX, Inc. ZEOXNCT05643729 Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)COPDsuspended20
2024-05-30 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT05797623 Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic AnemiaNon-severe Aplastic Anemiaunknown78
2024-05-30P3BayerNCT05915702 A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or SpinalContrast Enhancement in Magnetic Resonance Imaging; Central Nervous System Pathologycompleted321
2024-05-30P2Boehringer IngelheimNCT06082843 A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had BleedinHypertension, Portal; Liver Cirrhosisterminated22
2024-05-30 est.P2Chengdu CoenBiotech Co., LtdNCT06305104 Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years OldTuberculosisunknown420
2024-05-31P2Merck Sharp & Dohme LLC MRKNCT04428151 Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/MetasSquamous Cell Carcinoma of Head and Neckterminated408
2024-05-31P3Lupin Ltd.NCT04690556 Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMDNeovascular Age-related Macular Degenerationcompleted600
2024-05-31P2Calliditas Therapeutics Suisse SANCT05014672 A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver StiffnessPrimary Biliary Cholangitis; Liver Stiffnesscompleted76
2024-05-31 est.P2DermBiont, Inc.NCT05136144 Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic KeratosisSeborrheic Keratosisunknown70
2024-05-31P2Aston Sci. Inc.NCT05163223 Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerBreast Cancerterminated10
2024-05-31 est.P3Nihon Pharmaceutical Co., LtdNCT05177939 Phase III Clinical Study of NPB-01 in Patients With Autoimmune EncephalitisAutoimmune Encephalitisunknown40
2024-05-31P3Daiichi SankyoNCT05338970 HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI TheNonsquamous Non-small Cell Lung Cancer; EGFR L858R; EGFR Exon 19 Deletionactive not recruiting586
2024-05-31P1/P2AkesoNCT05559541 Study of AK119 Combined With AK104 in Patients With Advanced Solid TumorsSolid Tumor, Adultterminated33
2024-05-31P2ImaginAb, Inc.NCT05744128 CD8 Minibody Repeatability StudyMelanoma; Renal Cell Carcinomaterminated3
2024-05-31 est.P3NVP HealthcareNCT05856487 To Evaluate the Safety and Efficacy of NVP-2203 Tablet in PatientsCardiovascular Diseasesunknown228
2024-05-31 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT05865496 A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal PolypsSinusitis; Nasal Polyps; Polypsunknown90
2024-05-31P1/P2Thryv Therapeutics THRYNCT05906732 Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT SyndromLong QT Syndrometerminated42
2024-05-31P3BayerNCT05915728 A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems ofContrast Enhancement in Magnetic Resonance Imaging; Non-central Nervous System Pathologycompleted410
2024-05-31P3Regeneron Pharmaceuticals REGNNCT05989126 Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)Diabetic Macular Edema (DME); Neovascular Age-Related Macular Degeneration (nAMD)completed35
2024-05-31 est.P3Suzhou Kintor Pharmaceutical Inc,NCT06126965 Phase III Study of KX-826 With Adult Male Patients With AGAAndrogenetic Alopeciaunknown740
2024-05-31 est.P2Changchun GeneScience Pharmaceutical Co., Ltd.NCT06133166 A Study for the Treatment of Dry Eye in Postmenopausal WomenPostmenopausal Women With DEDunknown240
2024-05-31P2Soligenix SNGXNCT06149247 HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCLCutaneous T-Cell Lymphoma/Mycosis Fungoidescompleted10
2024-05-31P2LianBio LLCNCT06206278 Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ AdenocarcinomaGastric Cancer; Gastroesophageal Junction Adenocarcinomaterminated6

← 2024-04 | 2024-06 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.